Yi Jin, M.D.
CHIEF MEDICAL OFFICER & CHAIRMAN OF THE BOARD, BRAIN TREATMENT CENTER
Dr. Yi Jin has spent more than 30 years studying the functions, disorders and mysteries of the human brain. Now Chairman and Chief Medical Officer of the Brain Treatment Center, he pursues breakthrough research using non-invasive neuro modulation to modulate the brain’s neurons to treat a wide range of maladies, from autism to Alzheimer’s. Earlier this year he unveiled findings of his pilot double-blind study of 28 autistic patients and the technique he pioneered, known as Repetitive Transcranial Magnetic Stimulation (rTMS). A startling 80% of patients benefited with at least a 30% improvement in their symptoms—and half of them tested as “neurotypical,” that is, they tested as not being autistic at all. Dr. Jin holds six patents in the field. He created the Newport Brain Research Laboratory Inc., parent company of the Brain Treatment Center. BTC has four offices in Newport Beach, Calif.; Atlanta, Ga., Panama City, Panama; and Taipei, Taiwan; with plans to add six more by 2015. Dr. Jin also serves as Chief Medical Officer of NeoSync, a medical-device maker now in FDA clinical trials for using magnetic fields to ease depression. A graduate of Shanghai Medical University, Dr. Jin taught medicine at the University of California for 14 years before pioneering Magnetic Resonance Therapy and the BTC’s rTMS treatment practice. His therapy is applauded by another attendee at the VISIT conference this week: Dr. Kevin Murphy says rTMS was used successfully to treat his own 9-year-son for Asperger’s Syndrome.